Search Results - "Lydaki, E"

Refine Results
  1. 1
  2. 2

    HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report by Lydaki, E., Bolonaki, E., Nikoloudi, E., Chalkiadakis, E., Iniotaki-Theodoraki, A.

    Published in Transfusion and apheresis science (01-10-2005)
    “…TRALI, a serious complication of blood transfusion, is underdiagnosed. Anti-granulocyte and anti-HLA class I molecules in donors or recipients and very…”
    Get full text
    Journal Article
  3. 3

    Merocyanine 540 mediated photoirradiation of leukemic cells. In vitro inference on cell survival by Lydaki, E., Dimitriou, H., Papazoglou, Th, Bolonaki, E., Kalmanti, M.

    “…In order to evaluate the selective killing of merocyanine 540 (MC 540) mediated photoirradiation in neoplastic cells, bone narrow cells from children with…”
    Get full text
    Journal Article
  4. 4

    Altering interface detector positioning in combination with prestorage filtration to achieve a better quality of single donor platelet concentrates using the CS 3000 plus blood separator by Lydaki, E., Nikoloudi, E., Bolonaki, E., Mavroudis, D., Kandidaki, E.

    Published in Journal of clinical apheresis (2002)
    “…The interface detector (ID) is an optical density sensor that affects the quality of single donor platelet collection using the CS 3000 Plus blood separator…”
    Get full text
    Journal Article
  5. 5

    Treatment with recombinant human erythropoietin in children with malignancies by Bolonaki, I, Stiakaki, E, Lydaki, E, Dimitriou, H, Kambourakis, A, Kalmantis, T, Kalmanti, M

    Published in Pediatric hematology and oncology (1996)
    “…The effect of recombinant human erythropoietin (rHuEPO) on the anemia of cancer was examined in 15 children with hematologic malignancies (group I) and solid…”
    Get more information
    Journal Article
  6. 6

    Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte-macrophage colony-stimulating factor in neutropenic children with malignancies by Lydaki, E, Bolonaki, E, Stiakaki, E, Dimitriou, H, Kalmantis, T, Kalmanti, M

    Published in Pediatric hematology and oncology (1995)
    “…The difference between the effects of administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human…”
    Get more information
    Journal Article
  7. 7

    Congenital systemic Langerhans cell histiocytosis (report of two cases) by Stiakaki, E, Giannakopoulou, C, Kouvidi, E, Bolonaki, E, Kambourakis, A, Lydaki, E, Kalmanti, M

    Published in Haematologia (1997)
    “…Two cases of congenital systemic Langerhans cell histiocytosis (LCH), diagnosed and treated in our department from June 1995 until May 1996, are described. The…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Expression of the Epstein-Barr virus encoded latent membrane protein in tumor cells of Hodgkin's disease occurring in childhood by Kanavaros, P, Sakalidou, A, Gaulard, P, Jiwa, M, Delides, G, Tzardi, M, Kalmantis, T, Lydaki, E, Kazlaris, E, Kalmanti, M

    Published in Acta morphologica Hungarica (1992)
    “…Paraffin sections from 21 cases of Hodgkin's disease (HD), 28 cases of non-Hodgkin's lymphomas (NHL) and 34 cases of non-specific reactive lymphadenitides…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12

    Comparison of CD34+ cell collection efficiency on the COBE Spectra and Fenwal CS-3000 plus by Ford, C.D., Lehman, C., Strupp, A., Kelley, L.

    Published in Journal of clinical apheresis (2002)
    “…Optimal collections of mobilized CD34+ cells are important in terms of both patient toxicity and cost. The factors that determine CD34+ collection efficiency…”
    Get full text
    Journal Article
  13. 13

    Bone marrow purging by photodynamic treatment in children with acute leukemia: Cytoprotective action of Amifostine by Danilatou, Vassiliki, Lydaki, Evagelia, Dimitriou, Helen, Papazoglou, Theodore, Kalmanti, Maria

    Published in Leukemia research (01-05-2000)
    “…In order to evaluate the combined effect of Amifostine and Merocyanine 540 during photoirradiation in neoplastic cells, bone marrow cells from children with…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Phenotypic characteristics of cord blood hemopoietic cells by Dimitriou, Helen, Matsouka, Charis, Perdikoyanni, Chrissoula, Stiakaki, Eftichia, Bolonaki, Irene, Lydaki, Evangelia, Koumantakis, Eugene, Kalmanti, Maria

    Published in Leukemia research (01-08-1998)
    “…Bone marrow transplantation is limited due to the lack of HLA-matched donors and to the frequent occurrence of GvHD. Hemopoietic transplants using cord blood…”
    Get full text
    Journal Article
  18. 18

    Merocyanine 540 mediated photolysis of normal bone marrow, committed hemopoietic progenitors and neoplastic cells. Implications for bone marrow purging by Lydaki, Evaggelia, Dimitriou, Helen, Papazoglou, Theodore, Liu, Wen Qing, Kalmanti, Maria

    Published in Leukemia research (01-07-1997)
    “…The effect of merocyanine 540 (Mc 540) mediated photoirradiation on both neoplastic and normal hemopoietic progenitor cells was studied. Bone marrow (BM) cells…”
    Get full text
    Journal Article
  19. 19

    ONDANSETRON AND TROPISETRON IN THE CONTROL OF NAUSEA AND VOMITING IN CHILDREN RECEIVING COMBINED CANCER CHEMOTHERAPY by Eftichia Stiakaki, Savvas Savvas, Evaggelia Lydaki, Irene Bolonaki, Efrossini Kouvidi, Helen Dimitriou, Alexandros Kambourakis, Maria Kalmanti

    Published in Pediatric hematology and oncology (1999)
    “…Ondansetron (Zofron, Glaxo) and tropisetron (Navoban, Sandoz) are selective serotonin (5HT ) 3 antagonists that have proven very effective in the prevention of…”
    Get full text
    Journal Article
  20. 20

    IMMEDIATE FREE FLAP MANDIBULAR RECONSTRUCTION IN OSTEOSARCOMA OF THE MANDIBLE IN CHILDHOOD by Lydaki, Evaggelia, Bolonaki, Irine, Stiakaki, Eftichia, Kambourakis, Alexandros, Cordeiro, Peter B., Meyers, Paul A., Delides, Georgio, Hatzimanolis, Panogiotis, Kalmanti, Maria

    Published in Pediatric hematology and oncology (2000)
    “…Mandibular osteogenic sarcoma (OS) is a very rare entity in childhood. Adequate surgical rejection with a wide margin of normal tissue is the mainstay of…”
    Get full text
    Journal Article